The global market for Drug Discovery Informatics was estimated at US$2.5 Billion in 2023 and is projected to reach US$4.8 Billion by 2030, growing at a CAGR of 8.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Drug Discovery Informatics Market]( "Drug Discovery Informatics Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Software Component segment, which is expected to reach US$3 Billion by 2030 with a CAGR of 7.9%. The Services Component segment is also set to grow at 9.5% CAGR for the next 8-year period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $744.5 Million in 2023, and China, forecasted to grow at an impressive 7.9% CAGR to reach $824.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Drug Discovery Informatics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Drug Discovery Informatics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Drug Discovery Informatics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Certara USA, Inc., Charles River Laboratories International, Inc., Collaborative Drug Discovery, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 29 Featured):
- Certara USA, Inc.
- Charles River Laboratories International, Inc.
- Collaborative Drug Discovery, Inc.
- Dassault Systemes
- GVK Biosciences Pvt., Ltd.
- IBM Corporation
- Infosys Ltd.
- Jubilant Life Sciences Ltd.
- Novo Informatics Pvt., Ltd.
- Openeye Scientific Software
- PerkinElmer, Inc.
- Schrodinger LLC
- Selvita SA
- Thermo Fisher Scientific, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Drug Discovery Informatics - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
3. MARKET TRENDS & DRIVERS
- Growing Demand for Efficient Drug Development Processes Drives Growth in Drug Discovery Informatics Market
- Advances in Computational Biology and AI Propel Adoption of Drug Discovery Informatics Solutions
- Expansion of Genomics and Proteomics Research Spurs Demand for Drug Discovery Informatics Tools
- Technological Innovations in High-Throughput Screening Set the Stage for Market Growth in Drug Discovery Informatics
- Expansion of Informatics Solutions in Clinical Trials and Drug Development Spurs Demand for Advanced Tools
- Technological Innovations in Molecular Modeling and Simulation Propel Adoption in Drug Discovery Informatics
- Advances in Cloud-Based and SaaS Informatics Platforms Propel Growth in Collaborative Drug Development
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 3: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 4: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Sequencing & Target Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World 7-Year Perspective for Sequencing & Target Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Docking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 8: World 7-Year Perspective for Docking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 9: World Recent Past, Current & Future Analysis for Molecular Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 10: World 7-Year Perspective for Molecular Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World 7-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 14: World 7-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 15: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 16: World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 18: World 7-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 20: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 21: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 22: World 7-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 24: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- TABLE 25: World Drug Discovery Informatics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Drug Discovery Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: World 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
UNITED STATES
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 28: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 29: USA 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 30: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 31: USA 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 32: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 34: USA Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 35: USA 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
CANADA
- TABLE 36: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 37: Canada 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 38: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 40: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 41: Canada 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 42: Canada Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 43: Canada 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
JAPAN
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 44: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Japan 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 46: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 47: Japan 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 48: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 49: Japan 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 50: Japan Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: Japan 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
CHINA
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 52: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 53: China 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 54: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 55: China 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 56: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: China 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 58: China Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 59: China 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
EUROPE
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 60: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 61: Europe 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 62: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 64: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 65: Europe 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 66: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 67: Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
- TABLE 68: Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 69: Europe 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
FRANCE
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 70: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 71: France 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 72: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 73: France 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 74: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: France 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 76: France Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 77: France 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
GERMANY
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 78: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 79: Germany 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 80: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Germany 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 82: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 83: Germany 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 84: Germany Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 85: Germany 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
ITALY
- TABLE 86: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: Italy 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 88: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 89: Italy 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 90: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 91: Italy 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 92: Italy Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: Italy 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
UNITED KINGDOM
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 94: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 95: UK 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 96: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 97: UK 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 98: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: UK 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 100: UK Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 101: UK 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
REST OF EUROPE
- TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 103: Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 107: Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 109: Rest of Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
ASIA-PACIFIC
- Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by Component - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Component - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 113: Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2024 & 2030
- TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by Application - Drug Discovery and Drug Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 115: Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Application - Percentage Breakdown of Value Sales for Drug Discovery and Drug Development for the Years 2024 & 2030
- TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 117: Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Other End-Uses for the Years 2024 & 2030
Companies Mentioned
- Certara USA, Inc.
- Charles River Laboratories International, Inc.
- Collaborative Drug Discovery, Inc.
- Dassault Systemes
- GVK Biosciences Pvt., Ltd.
- IBM Corporation
- Infosys Ltd.
- Jubilant Life Sciences Ltd.
- Novo Informatics Pvt., Ltd.
- Openeye Scientific Software
- PerkinElmer, Inc.
- Schrodinger LLC
- Selvita SA
- Thermo Fisher Scientific, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 188 |
| Published | December 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.5 Billion |
| Forecasted Market Value ( USD | $ 4.8 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
